Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 19, 2013
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, has unveiled a new brand campaign, “I am INC Research,” that illustrates how the Company keeps customers, ...
read more
Tuesday, February 18, 2014
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced CEO Jamie Macdonald will participate in a panel discussion on evolving outsourcing models at ...
read more
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will feature Pierre Geoffroy, PhD, Vice President, Early Phase to discuss ethical principles related to ...
read more
Wednesday, February 08, 2012
INC Research
, LLC, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, today announced it has released a new white paper titled, "The Innovation Imperative: How CROs Are Driving The... read more
Thursday, November 08, 2012
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results has selected MetricStream to streamline Audit Management and Corrective Action/Preventive Action (CAPA) ...
read more
Tuesday, January 28, 2014
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the appointment of two senior executives to its oncology team. Asli Turkes, PhD has joined ...
read more
Tuesday, February 28, 2012
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will discuss the evolution of clinical development outsourcing trends at the Partnerships(TM) in Clinical ...
read more
Virtify, Inc.,a leading innovator in content and regulatory information management solutions for the life science industry, today announced Indiana University has signed an enterprise-level contract for its Clinical Trial Registration & Results (CTRR...
read more
Biosamples collected for future research provide a valuable source of material for the pharmaceutical industry to investigate new hypotheses related to drug efficacy and safety in a timely and efficient manner. However, collection of samples for ...
read more
Tuesday, October 05, 2021
Innodem Neurosciences announced that it has signed a multi-year partnership agreement with Novartis Pharmaceuticals Canada Inc. (Novartis) to conduct a breakthrough clinical trial to help people living with multiple sclerosis (MS).
read more
Wednesday, November 11, 2020
Inovalon announced the launch of an Inovalon ONE Platform configuration supporting multiple national vaccine adherence initiatives.
read more
Tuesday, February 26, 2013
Intelsius, a global designer, manufacturer and distributor of environmentally sustainable, temperature-controlled and regulatory-compliant packaging solutions, announced today that Stephen Healy has joined the company as European Sales Director. Mr. ...
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
Wednesday, February 02, 2022
IonsGate Preclinical Services Inc InSilicoTrials have announced a partnership to leverage innovative technology like Modeling and Simulation.
read more
IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, announced that F-star Therapeutics dosed the first patients in a Phase 1 clinical trial, with FS222, a CD137/PD-L1 bispecific antibody.
read more